195 related articles for article (PubMed ID: 32932580)
1. Identification of Potential Drug Targets in
Ibrahim KA; Helmy OM; Kashef MT; Elkhamissy TR; Ramadan MA
Pathogens; 2020 Sep; 9(9):. PubMed ID: 32932580
[TBL] [Abstract][Full Text] [Related]
2. Computer-Based Identification of Potential Druggable Targets in Multidrug-Resistant
Badie OH; Basyony AF; Samir R
Microorganisms; 2022 Oct; 10(10):. PubMed ID: 36296249
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K
Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential drug targets by subtractive genome analysis of Escherichia coli O157:H7: an in silico approach.
Mondal SI; Ferdous S; Jewel NA; Akter A; Mahmud Z; Islam MM; Afrin T; Karim N
Adv Appl Bioinform Chem; 2015; 8():49-63. PubMed ID: 26677339
[TBL] [Abstract][Full Text] [Related]
5. In silico quest for putative drug targets in Helicobacter pylori HPAG1: molecular modeling of candidate enzymes from lipopolysaccharide biosynthesis pathway.
Sarkar M; Maganti L; Ghoshal N; Dutta C
J Mol Model; 2012 May; 18(5):1855-66. PubMed ID: 21850571
[TBL] [Abstract][Full Text] [Related]
6. A comparative proteomic approach using metabolic pathways for the identification of potential drug targets against Helicobacter pylori.
Uddin R; Khalil W
Genes Genomics; 2020 May; 42(5):519-541. PubMed ID: 32193857
[TBL] [Abstract][Full Text] [Related]
7. Integrated Multi-omics, Virtual Screening and Molecular Docking Analysis of Methicillin-Resistant
Rahman S; Das AK
Int J Pept Res Ther; 2021; 27(4):2735-2755. PubMed ID: 34548853
[TBL] [Abstract][Full Text] [Related]
8. In Silico Subtractive Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against
Shami A; Alharbi NK; Al-Saeed FA; Alsaegh AA; Al Syaad KM; Abd El-Rahim IHA; Mostafa YS; Ahmed AE
Life (Basel); 2023 May; 13(5):. PubMed ID: 37240772
[No Abstract] [Full Text] [Related]
9. Proteome Exploration of
Khan MT; Mahmud A; Hasan M; Azim KF; Begum MK; Rolin MH; Akter A; Mondal SI
Microbiol Spectr; 2022 Aug; 10(4):e0037322. PubMed ID: 35863001
[TBL] [Abstract][Full Text] [Related]
10. Computational Guided Drug Targets Identification against Extended-Spectrum Beta-Lactamase-Producing Multi-Drug Resistant Uropathogenic
Kaur H; Modgil V; Chaudhary N; Mohan B; Taneja N
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509666
[TBL] [Abstract][Full Text] [Related]
11. Identification of New Drug Target in
Alhamhoom Y; Hani U; Bennani FE; Rahman N; Rashid MA; Abbas MN; Rastrelli L
Bioengineering (Basel); 2022 Sep; 9(9):. PubMed ID: 36134997
[No Abstract] [Full Text] [Related]
12. Core proteome mediated therapeutic target mining and multi-epitope vaccine design for Helicobacter pylori.
Rahman N; Ajmal A; Ali F; Rastrelli L
Genomics; 2020 Sep; 112(5):3473-3483. PubMed ID: 32562830
[TBL] [Abstract][Full Text] [Related]
13. Aspartate α-decarboxylase a new therapeutic target in the fight against
Ibrahim KA; Kashef MT; Elkhamissy TR; Ramadan MA; Helmy OM
Front Microbiol; 2022; 13():1019666. PubMed ID: 36523828
[TBL] [Abstract][Full Text] [Related]
14. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
[TBL] [Abstract][Full Text] [Related]
15. Identification of new protein coding sequences and signal peptidase cleavage sites of Helicobacter pylori strain 26695 by proteogenomics.
Müller SA; Findeiß S; Pernitzsch SR; Wissenbach DK; Stadler PF; Hofacker IL; von Bergen M; Kalkhof S
J Proteomics; 2013 Jun; 86():27-42. PubMed ID: 23665149
[TBL] [Abstract][Full Text] [Related]
16. Integrative proteomic and metabolomic analyses reveal the mechanism by which bismuth enables Helicobacter pylori eradication.
Yao X; Xiao S; Zhou L
Helicobacter; 2021 Dec; 26(6):e12846. PubMed ID: 34414638
[TBL] [Abstract][Full Text] [Related]
17. To study percentage distribution of target genes encoding proteins of different classes in Helicobacter pylori strain J99 and identification of potential therapeutic targets to reduce its proliferation.
Vaidya M; Panchal H
Int J Bioinform Res Appl; 2015; 11(1):1-9. PubMed ID: 25667382
[TBL] [Abstract][Full Text] [Related]
18. In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori.
Dutta A; Singh SK; Ghosh P; Mukherjee R; Mitter S; Bandyopadhyay D
In Silico Biol; 2006; 6(1-2):43-7. PubMed ID: 16789912
[TBL] [Abstract][Full Text] [Related]
19. Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection.
Li H; Wang R; Sun H
Acc Chem Res; 2019 Jan; 52(1):216-227. PubMed ID: 30596427
[TBL] [Abstract][Full Text] [Related]
20. Modeling Novel Putative Drugs and Vaccine Candidates against Tick-Borne Pathogens: A Subtractive Proteomics Approach.
Ali A; Ahmad S; Wadood A; Rehman AU; Zahid H; Qayash Khan M; Nawab J; Rahman ZU; Alouffi AS
Vet Sci; 2020 Sep; 7(3):. PubMed ID: 32906620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
